Toward a Bactericidal Oral Drug Combination for the Treatment of Mycobacterium abscessus Lung Disease
ACS Infectious Diseases · 2025
DOI: 10.1021/acsinfecdis.4c00948 ↗Kurz gefasst
Fachartikel in der Zeitschrift ACS Infectious Diseases, 2025. Verfasst von Jickky Palmae Sarathy und 10 weiteren Autor:innen. Beteiligte Einrichtung: Center for Discovery and Innovation, Hackensack Meridian Health, Nutley, New Jersey 07110, United States. Hauptthemen laut MEDLINE: Mycobacterium abscessus, Anti-Bacterial Agents, Mycobacterium Infections, Nontuberculous, Lung Diseases. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NIAID NIH HHS, National Institute of Allergy and Infectious Diseases, Cystic Fibrosis Foundation.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Center for Discovery and Innovation, Hackensack Meridian Health, Nutley, New Jersey 07110, United States.
- Center for Innovative Drug Development and Therapeutic Trials for Africa (CDT-Africa), Addis Ababa University, P.O. Box 9086, Addis Ababa 1165, Ethiopia.
- Mycobacteria Research Laboratories, Department of Microbiology, Immunology and Pathology, Colorado State University, Fort Collins, Colorado 80523, United States.
- Department of Medical Sciences, Hackensack Meridian School of Medicine, Nutley, New Jersey 07110, United States.
- Department of Microbiology and Immunology, Georgetown University, Washington, District of Columbia 20057, United States.
ORCID-Profile: Mercedes Gonzalez-Juarrero, Véronique Dartois, Thomas Dick
Förderung
- NIAID NIH HHS
- National Institute of Allergy and Infectious Diseases
- Cystic Fibrosis Foundation
Zitieren
APA
Sarathy, J. P., Xie, M., Wong, C. F., Negatu, D. A., Rodriguez, S., Zimmerman, M. D., Jimenez, D. C., Alshiraihi, I. M., Gonzalez-Juarrero, M., Dartois, V., & Dick, T. (2025). Toward a Bactericidal Oral Drug Combination for the Treatment of Mycobacterium abscessus Lung Disease. ACS Infectious Diseases. https://doi.org/10.1021/acsinfecdis.4c00948
Vancouver
Sarathy JP, Xie M, Wong CF, Negatu DA, Rodriguez S, Zimmerman MD, et al. Toward a Bactericidal Oral Drug Combination for the Treatment of Mycobacterium abscessus Lung Disease. ACS Infectious Diseases. 2025. doi:10.1021/acsinfecdis.4c00948
BibTeX
@article{Sarathy2025,
author = {Sarathy, Jickky Palmae and Xie, Min and Wong, Chui Fann and Negatu, Dereje A and Rodriguez, Suyapa and Zimmerman, Matthew D and Jimenez, Diana C and Alshiraihi, Ilham M and Gonzalez-Juarrero, Mercedes and Dartois, Véronique and Dick, Thomas},
title = {Toward a Bactericidal Oral Drug Combination for the Treatment of Mycobacterium abscessus Lung Disease},
journal = {ACS Infectious Diseases},
year = {2025},
doi = {10.1021/acsinfecdis.4c00948}
}
EUVIMED